Myriad Genetics, Inc. (MYGN) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 312.8M | 332.6M | 344.8M | 284.3M | 287.2M | 298M | 293.2M | 291.6M | 290.3M | 313.6M | 265.4M | 294.3M |
| Cash & Short-Term Investments | 124.4M | 149.6M | 145.4M | 74.4M | 91.8M | 102.4M | 99.9M | 97.3M | 104.3M | 140.9M | 86.3M | 121.6M |
| Cash Only | 124.4M | 149.6M | 145.4M | 74.4M | 91.8M | 102.4M | 99.9M | 92.4M | 96.9M | 132.1M | 76M | 102.8M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.9M | 7.4M | 8.8M | 10.3M | 18.8M |
| Accounts Receivable | 123.8M | 115.3M | 118M | 137M | 120.4M | 121.2M | 125.7M | 117.8M | 118.1M | 114.3M | 115.2M | 111.7M |
| Days Sales Outstanding | 53.69 | 51.15 | 57.02 | 54.96 | 55.5 | 53.93 | 52.51 | 50.75 | 52.3 | 53.7 | 54.39 | 57.23 |
| Inventory | 27.9M | 30.6M | 31.6M | 28.7M | 28.3M | 27.5M | 26.2M | 26.1M | 24.6M | 22M | 25.1M | 22.5M |
| Days Inventory Outstanding | 41.92 | 45.42 | 44.81 | 42.31 | 40.7 | 41.38 | 37.89 | 35.82 | 32.82 | 35.17 | 38.01 | 34.87 |
| Other Current Assets | 36.7M | 37.1M | 36M | 29.9M | 32.4M | 30.5M | 0 | 32M | 24.9M | 19.4M | 21.3M | 20.8M |
| Total Non-Current Assets | 360.9M | 374M | 383.3M | 392.4M | 718.9M | 729.6M | 788.1M | 793.5M | 820.2M | 832.9M | 883.7M | 892.9M |
| Property, Plant & Equipment | 162.5M | 163.4M | 162M | 164.2M | 167.4M | 172.4M | 172.8M | 172.8M | 177.4M | 180.6M | 224.7M | 218.6M |
| Fixed Asset Turnover | 1.23x | 1.29x | 1.26x | 1.29x | 1.15x | 1.22x | 1.23x | 1.21x | 1.13x | 0.97x | 0.87x | 0.87x |
| Goodwill | 47.1M | 51.6M | 51.6M | 51.6M | 286.3M | 286.3M | 286.3M | 286.3M | 287M | 287.4M | 286.6M | 287.2M |
| Intangible Assets | 145.7M | 153.4M | 163.1M | 169.5M | 257.5M | 262.4M | 312.5M | 319.5M | 340.9M | 349.5M | 356.6M | 358.8M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.2M |
| Other Non-Current Assets | 5.6M | 5.6M | 6.6M | 7.1M | 7.7M | 8.5M | 16.5M | 14.9M | 14.9M | 15.4M | 15.8M | 22.1M |
| Total Assets | 673.7M | 706.6M | 728.1M | 677.3M | 1.01B | 1.03B | 1.08B | 1.09B | 1.11B | 1.15B | 1.15B | 1.19B |
| Asset Turnover | 0.29x | 0.29x | 0.29x | 0.25x | 0.19x | 0.20x | 0.20x | 0.19x | 0.18x | 0.17x | 0.16x | 0.16x |
| Asset Growth % | -33.04% | -31.24% | -32.66% | -37.58% | -9.4% | -10.37% | -5.9% | -8.6% | -5.03% | -4.35% | -5.19% | -1.9% |
| Total Current Liabilities | 130.2M | 133.8M | 148M | 199.9M | 151.1M | 164.1M | 154.3M | 148.9M | 146.1M | 155.9M | 209.3M | 221.1M |
| Accounts Payable | 32.6M | 30M | 31.8M | 30.9M | 28.1M | 32.3M | 29.6M | 9M | 33.1M | 25.8M | 33.9M | 39.8M |
| Days Payables Outstanding | 44.86 | 45.12 | 46.59 | 43.79 | 44.05 | 47.7 | 27.96 | 29.74 | 41.49 | 44.58 | 58.86 | 60.06 |
| Short-Term Debt | 7.1M | 6.9M | 0 | 59.4M | 0 | 0 | 0 | 0 | 0 | 0 | 17.8M | 17M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -17.8M | 0 |
| Other Current Liabilities | 90.5M | 96.9M | 73.3M | 48M | 50.5M | 64.9M | 33.7M | 4M | 38.6M | 38.2M | 123.7M | 124.5M |
| Current Ratio | 2.40x | 2.49x | 2.33x | 1.42x | 1.90x | 1.82x | 1.90x | 1.96x | 1.99x | 2.01x | 1.27x | 1.33x |
| Quick Ratio | 2.19x | 2.26x | 2.12x | 1.28x | 1.71x | 1.65x | 1.73x | 1.78x | 1.82x | 1.87x | 1.15x | 1.23x |
| Cash Conversion Cycle | 50.75 | 51.44 | 55.24 | 53.47 | 52.14 | 47.61 | 62.44 | 56.83 | 43.63 | 44.29 | 33.55 | 32.04 |
| Total Non-Current Liabilities | 206.1M | 204.8M | 207.3M | 89.3M | 150.1M | 162.4M | 195.3M | 195.7M | 204.4M | 207.4M | 256.4M | 230.9M |
| Long-Term Debt | 204.4M | 202.9M | 119.5M | 0 | 59.3M | 39.6M | 39M | 38.8M | 38.7M | 38.5M | 183.6M | 186.8M |
| Capital Lease Obligations | 0 | 0 | 84.9M | 86.2M | 87.4M | 87.9M | 90.6M | 91.2M | 94.3M | 97.4M | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.7M | 3.7M |
| Other Non-Current Liabilities | 1.7M | 1.9M | 2.9M | 3.1M | 3.4M | 34.9M | 65.7M | 65.7M | 71.4M | 71.5M | 70.1M | 40.4M |
| Total Liabilities | 336.3M | 338.6M | 355.3M | 289.2M | 301.2M | 326.5M | 349.6M | 344.6M | 350.5M | 363.3M | 465.7M | 452M |
| Total Debt | 211.5M | 209.8M | 212.3M | 154.6M | 157.6M | 140.3M | 143.1M | 143.3M | 146.8M | 152.1M | 201.4M | 203.8M |
| Net Debt | 87.1M | 60.2M | 66.9M | 80.2M | 65.8M | 37.9M | 43.2M | 50.9M | 49.9M | 20M | 125.4M | 101M |
| Debt / Equity | 0.63x | 0.57x | 0.57x | 0.40x | 0.22x | 0.20x | 0.20x | 0.19x | 0.19x | 0.19x | 0.29x | 0.28x |
| Debt / EBITDA | - | 30.41x | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | 8.72x | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -6.17x | -1.02x | -5.89x | -219.40x | -35.75x | -54.86x | -25.50x | -45.50x | -50.80x | -34.89x | -60.20x | -231.20x |
| Total Equity | 337.4M | 368M | 372.8M | 388.1M | 704.9M | 701.1M | 731.7M | 740.5M | 760M | 783.2M | 683.4M | 735.2M |
| Equity Growth % | -52.14% | -47.51% | -49.05% | -47.59% | -7.25% | -10.48% | 7.07% | 0.72% | -9% | -11.58% | -25.44% | -22.4% |
| Book Value per Share | 3.60 | 3.94 | 4.00 | 4.20 | 7.71 | 7.70 | 8.05 | 8.17 | 8.45 | 9.10 | 8.34 | 9.00 |
| Total Shareholders' Equity | 337.4M | 368M | 372.8M | 388.1M | 704.9M | 701.1M | 731.7M | 740.5M | 760M | 783.2M | 683.4M | 735.2M |
| Common Stock | 900K | 900K | 900K | 900K | 900K | 900K | 900K | 900K | 900K | 900K | 800K | 800K |
| Retained Earnings | -1.16B | -1.12B | -1.11B | -1.09B | -756.9M | -756.8M | -714.3M | -692.2M | -655.5M | -629.5M | -598.3M | -537M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Accumulated OCI | 700K | 800K | -100K | -100K | -600K | -800K | -100K | -4M | -4.2M | -3.7M | -5.3M | -5.4M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |